Agarwal Shefali
SEC CIK 1746830 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | Dir | 10.5K | — | $36.8K | 4 | 2022-06-03 | 2022-06-09 |
Most active insiders at FATE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Valamehr Bahram | Pres, CEO, Dir | — | $168.1K |
| 2 | TAHL CINDY | See Remarks | — | $154.7K |
| 3 | Adawi Kamal | CFO | — | — |
| 4 | Redmile Group, LLC | Dir, 10% | — | — |
| 5 | EPSTEIN ROBERT S | Dir | — | — |
| 6 | RASTETTER WILLIAM H | Dir | — | — |
Agarwal Shefali made no open-market trades at FATE in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-13 | 2022-06-09 | FATE | FATE THERAPEUTICS INC | Agarwal Shefali | Dir | A - Grant | $0.00 | +8,650 | 10.5K | +470% | $0 |
| A | 2022-06-08 | 2022-06-03 | FATE | FATE THERAPEUTICS INC | Agarwal Shefali | Dir | S - Sale | — | 0 | 2,681 | New | — |
| 2022-06-08 | 2022-06-07 | FATE | FATE THERAPEUTICS INC | Agarwal Shefali | Dir | S - Sale | $21.89 | -841 | 1,840 | -31% | -$18.4K | |
| 2022-06-06 | 2022-06-03 | FATE | FATE THERAPEUTICS INC | Agarwal Shefali | Dir | S - Sale | $22.80 | -807 | 1,874 | -30% | -$18.4K |
Purchase Sale Sale after option exercise All abbreviations